Bevacizumab as Rescue Therapy for GI Bleeding in Hereditary Hemorrhagic Telangiectasia
Cureus · 01.04.2026
DOI: 10.7759/cureus.106279 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 01.04.2026. Verfasst von Abay A Gobezie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Howard University Hospital, Washington, DC, USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Howard University Hospital, Washington, DC, USA.
- Public Health, Project HOPE, Washington, DC, USA.
- Gastroenterology, AdventistHealth System, Altamonte Springs, USA.
- Gastroenterology, Howard University Hospital, Howard University College of Medicine, Washington, DC, USA.
- Gastroenterology, Howard University, Washington, DC, USA.
- Internal Medicine, Howard University, Washington, DC, USA.
Zitieren
APA
Gobezie, A. A., Adidam, S., Bisrat, M., Zinabu, S. W., Alemayehu, W., Alayu, K. S., Turaga, N. S. S., Aduli, F., Kibreab, A., & Michael, M. B. (2026). Bevacizumab as Rescue Therapy for GI Bleeding in Hereditary Hemorrhagic Telangiectasia. Cureus. https://doi.org/10.7759/cureus.106279
Vancouver
Gobezie AA, Adidam S, Bisrat M, Zinabu SW, Alemayehu W, Alayu KS, et al. Bevacizumab as Rescue Therapy for GI Bleeding in Hereditary Hemorrhagic Telangiectasia. Cureus. 2026. doi:10.7759/cureus.106279
BibTeX
@article{Gobezie2026,
author = {Gobezie, Abay A and Adidam, Sneha and Bisrat, Mekdem and Zinabu, Samrawit W and Alemayehu, Wondwossen and Alayu, Kalkidan S and Turaga, Naga Sai Shravan and Aduli, Farshad and Kibreab, Angesom and Michael, Miriam B},
title = {Bevacizumab as Rescue Therapy for GI Bleeding in Hereditary Hemorrhagic Telangiectasia},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.106279}
}
EUVIMED